Roger Bate: Eclectic booster of corporate views
The Wellcome Trust convened an “Opinion Formers Conference” on “Counterfeit Medicines: Perspectives and Action” on Monday 26 October 2009. Continue Reading
The Wellcome Trust convened an “Opinion Formers Conference” on “Counterfeit Medicines: Perspectives and Action” on Monday 26 October 2009. Continue Reading
On November 4-6, 2009, the next round of negotiations for the Anti-Counterfeiting Trade Negotiations (ACTA) will take place in Seoul, Korea. The following is another strange chapter in the secrecy surrounding this negotiation.
Since ACTA was first announced, KEI has pressed the negotiating governments to provide more transparency, including recently, for example
In discussions about a possible WIPO Treaty for persons who are blind or have other reading disabilities, there have been suggestions by some that voluntary licensing by rights holders presents a sufficient solution to the problem. I studied several publications since 1985 to take a closer look at this viewpoint and find out what were the common perceptions.
Korean civil society has asked KEI to disseminate this request for solidarity and action in their efforts to reduce the price of Gleevec, a leukemia treatment pill. The current price is approximately 2,300 USD per month for an adult patient and the Korean government has been sued by Novartis for trying to reduce the price a 14%. Korean civil society is also requesting Novartis to introduce a higher form, 400 mg, in Korea.
REQUEST for Solidarity:
1824
Louis Braille invented a system of reading and writing by means of raised dots.
1921
Continue Reading
——– Forwarded Message ——–
From: James Love
To: FOIARequests@cdc.gov
Subject: FOIA Request, IP aspects of pandemics
Date: Fri, 02 Oct 2009 16:36:44 -0400CDC/ATSDR FOIA Officer:
Lynn ArmstrongCDC/ATSDR
Attn: FOIA Office, MS-D54
1600 Clifton Road, N.E.
Atlanta, GA 30333Dear CDC FOIA officer:
Request Date: 9/30/2009
Request Reference Number: C6218The time period of my request is from 1/1/2009 to the present.
Description of request:
September 30, 2009.
USPTO FOIA Officer
United States Patent and Trademark Office
PO Box 1450
Alexandria, VA 22313-1450
efoia@uspto.govDear FOIA Officer:
India delivered the following intervention at MSF’s workshop at the World Trade Organization Public Forum today. The title of the MSF workshop was “Controversy at customs – the detention of medicines in transit: what impact on access to medicines?”
Controversy at customs – the detention of medicines in transit: what impact on access to medicines?
Wednesday 30 September 2009, 14:15 to 16:15
WTO building, Room A
This is the general statement delivered by the representative of the World Blind Union today (September 29, 2009) at the WIPO General Assemblies.
WBU statement:
The World Blind Union is the worldwide organisation representing the interests of 160 million blind and partially sighted persons in 177 member countries.